Girish Nair MD M.S.
Critical Care Medicine, Pleural Disease
Professor/Director ILD Program
Join to View Full Profile
740 N Limestone StLexington, KY 40508
Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Michigan School of Public HealthMS, Clinical Research and Biostatistics, 2017 - 2019
NYU Grossman Long Island School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2007 - 2010
University of Kerala Medical CollegeClass of 2003
Certifications & Licensure
KY State Medical License 2025 - 2026
MI State Medical License 2007 - 2025
NY State Medical License 2013 - 2016
PA State Medical License 2013 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Perfusion estimation from dynamic non-contrast computed tomography using self-supervised learning and a physics-inspired U-net transformer architecture.Yi-Kuan Liu, Jorge Cisneros, Girish Nair, Craig Stevens, Richard Castillo
International Journal of Computer Assisted Radiology and Surgery. 2025-05-01 - Modulation of the renin-angiotensin system against COVID-19: A path forward?Serge Camelo, Waly Dioh, J Pedro Teixeira, Laurence W Busse, Girish Nair
International Journal of Infectious Diseases. 2025-05-01 - CT-derived functional imaging biomarkers combined with FEV1 for predicting 10-year all-cause mortality in COPDGene cohort.Girish Nair, Yuying Judy Xing, Aaron Luong, Faiza Bashar, Amanda Nowacki
NPJ Biomedical Innovations. 2025-01-01
Press Mentions
Screening and Diagnosis of Pulmonary Hypertension Associated with Chronic Lung Disease (PH-CLD): A Consensus Statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionDecember 10th, 2024- Development and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality ModelNovember 22nd, 2024
- COVA Trial: Success for Sarconeos in Hospitalized COVID-19 PatientsJune 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
